Cite
HARVARD Citation
Lythgoe, M. et al. (2022). Approved anti-PD-1 monoclonal antibodies in China: A bridge too far for US approval. European journal of cancer. pp. 103-105. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lythgoe, M. et al. (2022). Approved anti-PD-1 monoclonal antibodies in China: A bridge too far for US approval. European journal of cancer. pp. 103-105. [Online].